Antifolates and MTHFR
Therapeutic Drug Monitoring of Mycophenolic Acid in Lupus Nephritis
Impact of Laboratory Practices on Interlaboratory Variability in Therapeutic Drug Monitoring of Immunosuppressive Drugs
Excel-Based Tool for Pharmacokinetically Guided Dose Adjustment of Paclitaxel
Influence of CYP2D6 and CYP3A4 Phenotypes, Drug Interactions, and Vitamin D Status on Tamoxifen Biotransformation
High-Dose Ribavirin Enhances Early Virological Response in Hepatitis C Genotype 1–Infected Patients
Lower Ribavirin Plasma Concentrations in HCV/HIV–Coinfected Patients Than in HCV-Monoinfected Patients Despite Similar Dosage
Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration–Time Curve to the Minimum Inhibitory Concentration ≥400 Target
Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease
Impact of Body Habitus on Phenytoin Levels Following Fosphenytoin Loading Dose in Pediatric Patients
The Influence of Plasma Albumin Concentration on the Analysis Methodology of Free Valproic Acid by Ultrafiltration and Its Application to Therapeutic Drug Monitoring
Therapeutic Drug Monitoring of Pentobarbital
Retrospective Evaluation of Milrinone Pharmacokinetics in Children With Kidney Injury
Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease
Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography–Mass Spectrometry
Methodological Considerations for Hair Cortisol Measurements in Children
Validation of a High-Performance Liquid Chromatography–Tandem Mass Spectrometry Method for the Determination of Perhexiline and Cis-Hydroxy-Perhexiline Plasma Concentrations
Generic Olanzapine Substitution in Patients With Schizophrenia
Stability Study of Isoniazid in Human Plasma
Dried Blood Spot Self-Sampling at Home for the Individualization of Tamoxifen Treatment